Neurosense Therapeutics Eulerpool Nieuws

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Aandeel Nieuws

Neurosense Therapeutics wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Neurosense Therapeutics nieuwsberichten verzamelen we hier.

• 16 augustus ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• 7 augustus ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• 7 augustus ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• 1 augustus ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• 1 augustus ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• 1 augustus ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• 9 juli ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• 1 juli ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• 27 juni ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• 24 juni ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results